Further validation assays using 16 cell lines (8 KRAS-mutant cell lines and 8 WT cell lines) supported the effect of verteporfin as a specific tumor growth inhibitor of KRAS-mutant lung cancer cells (Figure 1C and Supplemental Figure 1B). The gene discussed is KRAS; the disease is lung carcinoma.